Clinical Trial: Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis

U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07113366) titled 'Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis' on July 25.

Brief Summary: The study is designed to evaluate the efficacy and safety of a topical formulation containing Ficus awkeotsang Makino extract (FAE), derived from jelly fig, in participants with mild to moderate atopic dermatitis. Ficus awkeotsang is a traditional plant native to Taiwan.

Study Start Date: May 01, 2024

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis (AD)

Intervention: DRUG: FAE cream

Ficus awkeotsang Makino extract (FAE)

DRUG: Placebo

Placebo

Recruitment Status: COMPLETED

Sponsor: Kaohsiung Veterans General Hosp...